Adocia/ FR0011184241 /
07/06/2024 17:35:09 | Chg. +0.010 | Volume | Bid17:40:00 | Ask17:40:00 | High | Low |
---|---|---|---|---|---|---|
8.560EUR | +0.12% | 58,745 Turnover: 499,575.800 |
8.550Bid Size: 90 | 8.630Ask Size: 580 | 8.640 | 8.380 |
GlobeNewswire
28/03/2022
Adocia strengthens its cash position by 19 million euros following a real estate transaction
GlobeNewswire
14/10/2021
Adocia’s Partner Tonghua Dongbao Receives Clearance to Start Ultra-Rapid Insulin BioChaperone® Lispr...
GlobeNewswire
10/09/2021
Adocia to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
GlobeNewswire
29/06/2021
Adocia Initiates BC LisPram Phase 1 Clinical Trial in Pump for People with Type 1 Diabetes
GlobeNewswire
15/06/2021
ADOCIA Announces M1Pram Clinical Data Presentation at the American Diabetes Association® 81ˢᵗ Scient...
GlobeNewswire
26/05/2021
Adocia Expands Clinical Development to Obesity with Patent Applications on Short-Acting Multihormona...
GlobeNewswire
11/12/2018
Biopharmaceutical Drug Delivery Device Technology - Global Markets to 2023: Trends & Developments
GlobeNewswire
25/07/2018
Subcutaneous Biologics, Technologies and Drug Delivery Systems Market, 2030
GlobeNewswire
11/09/2014
Wolters Kluwer Included in Dow Jones Sustainability Indices for Eighth Consecutive Year
GlobeNewswire
26/08/2014
Wolters Kluwer Legal & Regulatory Solutions Announces Gregory Samios as Wolters Kluwer Law & Busines...
GlobeNewswire
22/07/2014
Wolters Kluwer Legal & Regulatory to Acquire LexisNexis Legal Business in Poland and Divest Canadian...
GlobeNewswire
23/04/2014
Wolters Kluwer Shareholders Approve Dividend and New Supervisory Board Member Appointment
GlobeNewswire
07/04/2014
Wolters Kluwer Completes Acquisition of Remaining 62% of Third Coast Holdings